Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility and efficacy of subcutaneous vs intravenous plerixafor for allogeneic stem cell mobilization
2010-023436-16Phase 2Active
- Sponsor
- HOVON
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of plerixafor in stem cell transplant (SCT) (2 arms), sponsored by HOVON. Primary endpoint: Successful harvest rate. Started Apr 2011; status: active.
02
Drugs
plerixafor
03
Conditions
stem cell transplant (SCT)
Beyond the preview
Go deeper on 2010-023436-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023436-16.